Literature DB >> 12525424

Ehrlichia chaffeensis: a prototypical emerging pathogen.

Christopher D Paddock1, James E Childs.   

Abstract

Ehrlichia chaffeensis is an obligately intracellular, tick-transmitted bacterium that is maintained in nature in a cycle involving at least one and perhaps several vertebrate reservoir hosts. The moderate to severe disease caused by E. chaffeensis in humans, first identified in 1986 and reported for more than 1,000 patients through 2000, represents a prototypical "emerging infection." Knowledge of the biology and natural history of E. chaffeensis, and of the epidemiology, clinical features, and laboratory diagnosis of the zoonotic disease it causes (commonly referred to as human monocytic ehrlichiosis [HME]) has expanded considerably in the period since its discovery. In this review, we summarize briefly the current understanding of the microbiology, pathogenesis, and clinical manifestations associated with this pathogen but focus primarily on discussing various ecological factors responsible for the recent recognition of this important and potentially life-threatening tick-borne disease. Perhaps the most pivotal element in the emergence of HME has been the staggering increases in white-tailed deer populations in the eastern United States during the 20th century. This animal serves as a keystone host for all life stages of the principal tick vector (Amblyomma americanum) and is perhaps the most important vertebrate reservoir host for E. chaffeensis. The contributions of other components, including expansion of susceptible human populations, growth and broadening geographical distributions of other potential reservoir species and A. americanum, and improvements in confirmatory diagnostic methods, are also explored.

Entities:  

Mesh:

Year:  2003        PMID: 12525424      PMCID: PMC145301          DOI: 10.1128/CMR.16.1.37-64.2003

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  253 in total

1.  Human granulocytic ehrlichiosis in New York.

Authors:  B J Wallace; G Brady; D M Ackman; S J Wong; G Jacquette; E E Lloyd; G S Birkhead
Journal:  Arch Intern Med       Date:  1998-04-13

Review 2.  Childhood infection caused by Ehrlichia canis or a closely related organism.

Authors:  M S Edwards; J E Jones; D L Leass; J W Whitmore; J E Dawson; D B Fishbein
Journal:  Pediatr Infect Dis J       Date:  1988-09       Impact factor: 2.129

3.  The 120 kDa outer membrane protein of Ehrlichia chaffeensis: preferential expression on dense-core cells and gene expression in Escherichia coli associated with attachment and entry.

Authors:  V L Popov; X j Yu; D H Walker
Journal:  Microb Pathog       Date:  2000-02       Impact factor: 3.738

4.  Ehrlichiosis with severe pulmonary manifestations despite early treatment.

Authors:  R A Weaver; G Virella; A Weaver
Journal:  South Med J       Date:  1999-03       Impact factor: 0.954

5.  Short report: geographic distribution of different genetic types of Ehrlichia chaffeensis.

Authors:  X Yu; J F Piesman; J G Olson; D H Walker
Journal:  Am J Trop Med Hyg       Date:  1997-06       Impact factor: 2.345

6.  Comparison of Ehrlichia chaffeensis recombinant proteins for serologic diagnosis of human monocytotropic ehrlichiosis.

Authors:  X J Yu; P A Crocquet-Valdes; L C Cullman; V L Popov; D H Walker
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Glycosylation of homologous immunodominant proteins of Ehrlichia chaffeensis and Ehrlichia canis.

Authors:  J W McBride; X J Yu; D H Walker
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

8.  Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis.

Authors:  J S Dumler; J E Dawson; D H Walker
Journal:  Hum Pathol       Date:  1993-04       Impact factor: 3.466

9.  AIDS in rural eastern North Carolina--patient migration: a rural AIDS burden.

Authors:  R L Rumley; N C Shappley; L E Waivers; J D Esinhart
Journal:  AIDS       Date:  1991-11       Impact factor: 4.177

10.  Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness.

Authors:  A G Barbour; G O Maupin; G J Teltow; C J Carter; J Piesman
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

View more
  165 in total

1.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Arbobacteria - Pathogens Transmittable by Arthropods.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Obligate intracellular bacterium Ehrlichia inhibiting mitochondrial activity.

Authors:  Yan Liu; Zhikai Zhang; Yongquan Jiang; Lihong Zhang; Vsevolod L Popov; Jianzhi Zhang; David H Walker; Xue-jie Yu
Journal:  Microbes Infect       Date:  2010-11-09       Impact factor: 2.700

4.  Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway.

Authors:  Mohd Akhlakur Rahman; Zhihui Cheng; Junji Matsuo; Yasuko Rikihisa
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

5.  Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles.

Authors:  Jian-zhi Zhang; Mala Sinha; Bruce A Luxon; Xue-jie Yu
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Attenuated Mutants of Ehrlichia chaffeensis Induce Protection against Wild-Type Infection Challenge in the Reservoir Host and in an Incidental Host.

Authors:  Arathy D S Nair; Chuanmin Cheng; Deborah C Jaworski; Suhasini Ganta; Michael W Sanderson; Roman R Ganta
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

7.  Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles.

Authors:  Weichao Bao; Yumi Kumagai; Hua Niu; Mamoru Yamaguchi; Koshiro Miura; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

8.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Molecular characterization of antibody epitopes of Ehrlichia chaffeensis ankyrin protein 200 and tandem repeat protein 47 and evaluation of synthetic immunodeterminants for serodiagnosis of human monocytotropic ehrlichiosis.

Authors:  Tian Luo; Xiaofeng Zhang; William L Nicholson; Bing Zhu; Jere W McBride
Journal:  Clin Vaccine Immunol       Date:  2009-12-02

Review 10.  Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins.

Authors:  Yasuko Rikihisa; Mingqun Lin
Journal:  Curr Opin Microbiol       Date:  2010-01-05       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.